Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 3:27 AM
Ignite Modification Date:
2025-12-26 @ 2:08 AM
NCT ID:
NCT04467905
Pre Assignment Details:
Of the 69 participants randomized, 13 (18.8%) did not receive etripamil/placebo because of the following reasons: baseline heart rate \<110bpm (n=5), converted to sinus rhythm (n=3), technical issue with Holter and ECGs were missing (n=3), hemodynamic instability (n=1), site misinterpretation of protocol (n=1).
Recruitment Details:
Participants with atrial fibrillation and ventricular rate =\>110bpm over 1 minute were screened to participate in the study (first participant enrolled on 19-Nov-2020, last participant completed 10-Aug-2023). Overall, 87 participants were screened and from those, 69 participants were randomized. From those participants, 56 participants received etripamil or placebo.
Study:
NCT04467905
Study Brief:
Results Section:
NCT04467905